Jia-Sin Liu, Master of Science

NHRI
Division of Preventive Medicine and Health Services Research, Institute of Population Health Sciences
35 Keyan Road, Zhunan
Miaoli County Taiwan sgazn.tw@gmail.com

5076.0 Use of angiotensin converting enzyme inhibitor and angiotensin II receptor blockers (ACEI/ARB) in diabetic patients with late stage chronic kidney disease (CKD) reduces the risk for mortality and progression to dialysis